COMPASS Pathways Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Public

  • Employees
  • 156

Employees

  • Stock Symbol
  • CMPS

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $8.06
  • (As of Friday Closing)

COMPASS Pathways General Information

Description

Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.

Contact Information

Formerly Known As
COMPASS Pathways Technologies, Compass Rx
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 3rd Floor, 1 Ashley Road
  • Cheshire
  • Altrincham WA14 2DT
  • England, United Kingdom
Primary Industry
Biotechnology
Other Industries
Clinics/Outpatient Services
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 3rd Floor, 1 Ashley Road
  • Cheshire
  • Altrincham WA14 2DT
  • England, United Kingdom

COMPASS Pathways Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

COMPASS Pathways Stock Performance

As of 20-Nov-2026, COMPASS Pathways’s stock price is $8.06. Its current market cap is $1.14B with 142M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$8.06 $8.65 $4.88 - $15.87 $1.14B 142M 3.07M -$2.35

COMPASS Pathways Financials Summary

As of 30-Sep-2026, COMPASS Pathways has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,343,985 511,765 84,231 326,089
Revenue 0 0 0 0
EBITDA (275,294) (292,784) (157,084) (119,861)
Net Income (266,301) (287,862) (155,122) (118,464)
Total Assets 519,096 210,349 213,666 275,987
Total Debt 54,394 35,035 32,193 33,050
Public Fundamental Data provided by Morningstar, Inc. disclaimer

COMPASS Pathways Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore COMPASS Pathways‘s full profile, request access.

Request a free trial

COMPASS Pathways Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore COMPASS Pathways‘s full profile, request access.

Request a free trial

COMPASS Pathways Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its resear
Biotechnology
Altrincham, United Kingdom
156 As of 2025

New York, NY
 

Toronto, Canada
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

COMPASS Pathways Competitors (8)

One of COMPASS Pathways’s 8 competitors is AtaiBeckley, a Formerly VC-backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AtaiBeckley Formerly VC-backed New York, NY
Silo Wellness Corporation Toronto, Canada
Revive Therapeutics Corporation Toronto, Canada
Minerva Neurosciences Formerly VC-backed Burlington, MA
Definium Therapeutics Formerly VC-backed New York, NY
You’re viewing 5 of 8 competitors. Get the full list »

COMPASS Pathways Patents

COMPASS Pathways Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026220029-A1 Pyrrolidine-indole compounds and compositions comprising the same which are modulators of 5- ht2a Pending 17-Apr-2025
US-20260327205-A1 C-linked pyrrolidine-indole compounds and compositions comprising the same Pending 11-Apr-2025
WO-2026215478-A1 Pyrrolidine-indole compounds as 5-ht2a receptor agonists Pending 11-Apr-2025
US-20260021070-A1 Subcutaneous formulations comprising psilocybin derivatives Pending 19-Jul-2024
WO-2026017869-A1 Subcutaneous formulations comprising psilocybin derivatives Pending 19-Jul-2024 A61K9/0019
To view COMPASS Pathways’s complete patent history, request access »

COMPASS Pathways Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

COMPASS Pathways Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore COMPASS Pathways‘s full profile, request access.

Request a free trial

COMPASS Pathways Investments (2)

COMPASS Pathways’s most recent deal was a Corporate Asset Purchase with Compass Pathways (Intellectual Property Asset Portfolio). The deal was made on 14-Sep-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Compass Pathways (Intellectual Property Asset Portfolio) 14-Sep-2021 Corporate Asset Purchase Buildings and Property
Delix Therapeutics 06-Mar-2020 Corporate Drug Discovery
To view COMPASS Pathways’s complete investments history, request access »

COMPASS Pathways ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view COMPASS Pathways’s complete esg history, request access »

COMPASS Pathways Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Compass Pathfinder Holdings Altrincham, United Kingdom 2017

COMPASS Pathways FAQs

  • When was COMPASS Pathways founded?

    COMPASS Pathways was founded in 2016.

  • Where is COMPASS Pathways headquartered?

    COMPASS Pathways is headquartered in Altrincham, United Kingdom.

  • What is the size of COMPASS Pathways?

    COMPASS Pathways has 156 total employees.

  • What industry is COMPASS Pathways in?

    COMPASS Pathways’s primary industry is Biotechnology.

  • Is COMPASS Pathways a private or public company?

    COMPASS Pathways is a Public company.

  • What is COMPASS Pathways’s stock symbol?

    The ticker symbol for COMPASS Pathways is CMPS.

  • What is the current stock price of COMPASS Pathways?

    As of 20-Nov-2026 the stock price of COMPASS Pathways is $8.06.

  • What is the current market cap of COMPASS Pathways?

    The current market capitalization of COMPASS Pathways is $1.14B.

  • Who are COMPASS Pathways’s competitors?

    AtaiBeckley, Silo Wellness, Revive Therapeutics, Minerva Neurosciences, and Definium Therapeutics are some of the 8 competitors of COMPASS Pathways.

  • What is COMPASS Pathways’s annual earnings per share (EPS)?

    COMPASS Pathways’s EPS for 12 months was -$2.35.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process